In:
Annals of Clinical Microbiology and Antimicrobials, Springer Science and Business Media LLC, Vol. 4, No. 1 ( 2005-12)
Kurzfassung:
Mutations in a small region of the rpoB gene are responsible for most rifamycin resistance in Mycobacterium tuberculosis . In this study we have sequentially generated resistant strains to first rifampicin and then rifabutin. Portions of the rpoB gene were sequenced from 131 randomly selected mutants. Second round selection resulted in a changed frequency of specific mutations. Methods Mycobacterium tuberculosis (strain Mtb72) rifamycin resistant mutants were selected in vitro with either rifampicin or rifabutin. One mutant R190 ( rpoB S522L) selected with rifampicin had a rifampicin MIC of 32 μg/ml but remained sensitive to rifabutin (MIC 〈 0.8 μg/ml). This mutant was subjected to a second round of selection with rifabutin. Results All 105 first round resistant mutants derived from the parent strain (Mtb72) screened acquired mutations within the 81 bp rpoB hotspot. When the rifampicin resistant but rifabutin sensitive S522L mutant was subjected to a second round of selection, single additional rpoB mutations were identified in 24 (92%) of 26 second round mutants studied, but 14 (54%) of these strains contained mutations outside the 81 bp hotspot (codons 144, 146, 148, 505). Additionally, spontaneous rifabutin resistant mutants were produced at 〉 10 times the frequency by the S522L mutant than the parent strain. Conclusion First round selection of mutation S522L with rifampicin increased the frequency and changed the spectrum of mutations identified after selection with rifabutin.
Materialart:
Online-Ressource
ISSN:
1476-0711
DOI:
10.1186/1476-0711-4-9
Sprache:
Englisch
Verlag:
Springer Science and Business Media LLC
Publikationsdatum:
2005
ZDB Id:
2097873-X
SSG:
15,3
